Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Precipio Inc (PRPO)

Precipio Inc (PRPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,412
  • Shares Outstanding, K 22,709
  • Annual Sales, $ 8,850 K
  • Annual Income, $ -8,530 K
  • 60-Month Beta 2.25
  • Price/Sales 2.72
  • Price/Cash Flow N/A
  • Price/Book 1.08
Trade PRPO with:

Options Overview Details

View History
  • Implied Volatility 378.41% ( +173.71%)
  • Historical Volatility 70.34%
  • IV Percentile 90%
  • IV Rank 39.82%
  • IV High 850.85% on 04/27/22
  • IV Low 65.84% on 05/16/22
  • Put/Call Vol Ratio 34.00
  • Today's Volume 35
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 3,347
  • Open Int (30-Day) 2,711

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9100 +14.29%
on 05/12/22
1.2900 -19.38%
on 05/10/22
-0.1200 (-10.34%)
since 04/18/22
3-Month
0.9100 +14.29%
on 05/12/22
1.7700 -41.24%
on 04/04/22
-0.2600 (-20.00%)
since 02/18/22
52-Week
0.9100 +14.29%
on 05/12/22
5.3000 -80.38%
on 05/20/21
-2.9700 (-74.06%)
since 05/18/21

Most Recent Stories

More News
Precipio Signs First IV-Cell Customer Agreement

Laboratory operating both HemeScreen® & IV-Cell® demonstrates significant cross-sell potential...

PRPO : 1.0400 (-3.26%)
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference

NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its...

PRPO : 1.0400 (-3.26%)
Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call

Conference Call to be held on Monday, April 4th, 2022 at 5:00 PM EST...

PRPO : 1.0400 (-3.26%)
Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO

NEW HAVEN, Conn., March 21, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that Mr. Carl...

PRPO : 1.0400 (-3.26%)
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022

NEW HAVEN, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced its unaudited and...

PRPO : 1.0400 (-3.26%)
New York State Approves Precipio’s HemeScreen for POL clinical use

New York Cancer & Blood POL will commence the use of HemeScreen in its laboratory...

PRPO : 1.0400 (-3.26%)
Precipio Announces Q3-2021 and year-end Shareholder Update Call

Conference Call to be held on Monday, November 15th, 2021 at 5:00 PM EST...

PRPO : 1.0400 (-3.26%)
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory

HemeScreen Assays will enable AON to deliver rapid patient diagnostics for hematologic malignancies through advanced molecular screening technology

PRPO : 1.0400 (-3.26%)
Precipio Reschedules Q2-2021 Shareholder Update Call

Due to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM EST

PRPO : 1.0400 (-3.26%)
Precipio Corrects Announcement of Q2-2021 Shareholder Update Call

(Reference to “year-end” was included incorrectly)

PRPO : 1.0400 (-3.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class...

See More

Key Turning Points

3rd Resistance Point 1.1400
2nd Resistance Point 1.1200
1st Resistance Point 1.0800
Last Price 1.0400
1st Support Level 1.0200
2nd Support Level 1.0000
3rd Support Level 0.9600

See More

52-Week High 5.3000
Fibonacci 61.8% 3.6230
Fibonacci 50% 3.1050
Fibonacci 38.2% 2.5870
Last Price 1.0400
52-Week Low 0.9100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar